What is step therapy in the PA process?

What is step therapy in the PA process?

• A. A tool used by payers in the PA process for more expensive medications in a therapeutic class. Usually follows medication tier in formulary
• B. An approval that bypasses PA for urgent needs
• C. A system to track patient adherence
• D. A process to switch to generic medication without PA

Answer: (A)

Step therapy in the prior authorization process is a policy that requires using a lower-cost, preferred medication within a therapeutic class before the payer will cover a more expensive option. In practice, when a clinician prescribes a higher-cost drug, the insurer may require the patient to first try a recommended, less costly alternative (often aligned with formulary tiers) and to document that the first option was tried or is unsuitable. If the patient cannot tolerate or respond to the initial drug, coverage can be approved for the higher-cost medication. The goal is to balance clinical effectiveness with cost containment, allowing exceptions when a justified medical need is shown. It isn’t about bypassing PA—even in urgent cases—or about tracking adherence, and it isn’t simply a switch to a generic drug without PA, though generics may be the preferred first-line option within the step.

Step therapy in the prior authorization process is a policy that requires using a lower-cost, preferred medication within a therapeutic class before the payer will cover a more expensive option. In practice, when a clinician prescribes a higher-cost drug, the insurer may require the patient to first try a recommended, less costly alternative (often aligned with formulary tiers) and to document that the first option was tried or is unsuitable. If the patient cannot tolerate or respond to the initial drug, coverage can be approved for the higher-cost medication. The goal is to balance clinical effectiveness with cost containment, allowing exceptions when a justified medical need is shown.

It isn’t about bypassing PA—even in urgent cases—or about tracking adherence, and it isn’t simply a switch to a generic drug without PA, though generics may be the preferred first-line option within the step.